EdgarLookup
8-K/A

8-K/A

Company
Oruka Therapeutics, Inc.
Filed
June 11, 2015
Period of Report
June 10, 2015
Accession Number
0001564590-15-005032
View Document ↗ View on SEC.gov ↗